Figure 1From: Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis Rifampin plasma concentrations (μg/ml) in human immunodeficiency virus (HIV)-infected and HIV-uninfected children being treated for tuberculosis determined on enrolment (A) and after 4 months of treatment (B).Back to article page